Buffett just messed things up for Teva short-sellers
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
IT'S not like there was any real risk in shorting an easy target like Teva Pharmaceutical Industries. Warren Buffett could come along to destroy your bet, but what were the odds of that happening?
Oops.
It's not a happy Valentine's Day for Teva short-sellers. After the market closed Wednesday, a filing from Buffett's Berkshire Hathaway disclosed that it made only one new investment during the latest quarter. Unluckily for Teva bears, it was the Israeli generic-drug maker they've been betting against to the tune of US$1.2 billion.
Share with us your feedback on BT's products and services
TRENDING NOW
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Singapore has experience to explore more underground spaces for fuel reserves: Tan See Leng
Defensive S-Reits emerge as analysts’ top picks amid macro jitters
